Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood

Documenti analoghi

• Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
  di: Afif Nakhleh, et al.
  Pubblicazione: (2024)
• Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach
  di: Anders Strathe, et al.
  Pubblicazione: (2026)
• Supporting Weight Management for Kidney Transplant Candidates in People With Obesity on Haemodialysis: The First National Survey of UK Kidney Healthcare Providers
  di: Adrian Brown, et al.
  Pubblicazione: (2026)
• Comment on ‘Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach’
  di: Vijay Kumar K. V., et al.
  Pubblicazione: (2026)
• Diabetes, Obesity and Metabolism
  Pubblicazione: (2026)